Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuefu Zhuyu Capsule for acute chest pain after thoracoscopic surgery for early NSCLC
ChiCTR2100051431Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Xuefu Zhuyu Jiaonang in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Pain numerical rating scale. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
Xuefu Zhuyu Jiaonang
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2100051431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051431.